Electroporation methods for introducing bioactive agents into cells

Details for Australian Patent Application No. 2003219805 (hide)

Owner Eisai Corporation of North America

Inventors Hedley, Mary Lynne; Barman, Shikha P; Wang, Daqing

Agent Davies Collison Cave

Pub. Number AU-B-2003219805

PCT Number PCT/US03/04937

PCT Pub. Number WO2003/070905

Priority 60/357,542 15.02.02 US

Filing date 18 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 4 June 2009

International Classifications

A61N 1/30 (2006.01) Electrotherapy - Apparatus for iontophoresis or cataphoresis

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

C12N 15/88 (2006.01) Mutation or genetic engineering

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/357,542 15.02.02 US

9 October 2003 Application Open to Public Inspection

  Published as AU-B-2003219805

11 September 2008 Alteration of Name

  The name of the applicant has been altered to MGI PHARMA Biologics, Inc.

30 April 2009 Assignment before Grant

  MGI PHARMA Biologics, Inc. The application has been assigned to Eisai Corporation of North America

4 June 2009 Application Accepted

  Published as AU-B-2003219805

1 October 2009 Standard Patent Sealed

29 October 2009 Assignment Registered

  Eisai Corporation of North America The patent has been assigned to Eisai Inc.

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219806-Precise breeding

2003219804-Removable closure assembly for a water treatment system